Renaissance Technologies LLC Sells 21,611 Shares of Guardian Pharmacy Services, Inc. $GRDN

Renaissance Technologies LLC cut its stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 17.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 99,989 shares of the company’s stock after selling 21,611 shares during the period. Renaissance Technologies LLC owned 0.20% of Guardian Pharmacy Services worth $3,766,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in GRDN. Dynamic Technology Lab Private Ltd acquired a new position in shares of Guardian Pharmacy Services in the first quarter valued at approximately $233,000. JPMorgan Chase & Co. boosted its stake in Guardian Pharmacy Services by 48.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 6,027 shares of the company’s stock valued at $128,000 after purchasing an additional 1,956 shares during the period. Legal & General Group Plc grew its holdings in Guardian Pharmacy Services by 1,783.1% in the 2nd quarter. Legal & General Group Plc now owns 14,895 shares of the company’s stock valued at $317,000 after buying an additional 14,104 shares in the last quarter. Rhumbline Advisers grew its holdings in Guardian Pharmacy Services by 121.1% in the 2nd quarter. Rhumbline Advisers now owns 16,174 shares of the company’s stock valued at $345,000 after buying an additional 8,860 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in Guardian Pharmacy Services during the 2nd quarter worth $214,000.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on GRDN shares. Bank of America lifted their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Zacks Research downgraded shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Wall Street Zen cut shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Truist Financial boosted their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. Finally, Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $43.83.

Guardian Pharmacy Services Stock Performance

NYSE:GRDN opened at $43.35 on Friday. The stock has a fifty day moving average price of $40.93 and a 200-day moving average price of $37.09. The company has a market cap of $2.16 billion, a price-to-earnings ratio of 42.09, a PEG ratio of 2.59 and a beta of 0.10. Guardian Pharmacy Services, Inc. has a fifty-two week low of $19.30 and a fifty-two week high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The company had revenue of $351.77 million for the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a return on equity of 31.45% and a net margin of 4.50%. Research analysts predict that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.